ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 233 filers reported holding ROYALTY PHARMA PLC in Q3 2021. The put-call ratio across all filers is 0.36 and the average weighting 1.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $66,168,732 | -2.6% | 2,438,052 | +10.4% | 0.02% | +4.8% |
Q2 2023 | $67,901,176 | +26.9% | 2,208,887 | +48.7% | 0.02% | +16.7% |
Q1 2023 | $53,520,274 | -2.4% | 1,485,436 | +7.1% | 0.02% | -5.3% |
Q4 2022 | $54,820,000 | -0.7% | 1,387,148 | +0.9% | 0.02% | -5.0% |
Q3 2022 | $55,216,000 | +1.8% | 1,374,241 | +6.6% | 0.02% | +5.3% |
Q2 2022 | $54,220,000 | +7.7% | 1,289,699 | -0.2% | 0.02% | +26.7% |
Q1 2022 | $50,331,000 | -2.9% | 1,292,117 | -0.7% | 0.02% | +7.1% |
Q4 2021 | $51,819,000 | +11.0% | 1,300,671 | +0.7% | 0.01% | -6.7% |
Q3 2021 | $46,702,000 | -15.7% | 1,292,261 | -4.4% | 0.02% | -11.8% |
Q2 2021 | $55,427,000 | +0.5% | 1,352,176 | +7.0% | 0.02% | -5.6% |
Q1 2021 | $55,153,000 | +39.0% | 1,263,884 | +59.4% | 0.02% | +28.6% |
Q4 2020 | $39,672,000 | +51.9% | 792,683 | +27.7% | 0.01% | +27.3% |
Q3 2020 | $26,115,000 | -62.3% | 620,718 | -56.5% | 0.01% | -63.3% |
Q2 2020 | $69,201,000 | – | 1,425,370 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Siguler Guff Advisers, LLC | 3,391,754 | $122,204,897 | 47.65% |
Vantage Consulting Group Inc | 1,022,194 | $36,829,650 | 20.91% |
Indie Asset Partners, LLC | 433,000 | $15,600,990 | 18.22% |
Overbrook Management Corp | 578,783 | $20,853,551 | 5.46% |
Silicon Valley Community Foundation | 1,032,320 | $37,194,490 | 5.36% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 3,047,049 | $109,785,175 | 4.64% |
Geo Capital Gestora de Recursos Ltd | 142,748 | $5,143 | 3.81% |
Renaissance Capital LLC | 123,913 | $4,464,585 | 3.31% |
Rokos Capital Management LLP | 1,106,813 | $40,077,698 | 2.96% |
Lagoda Investment Management, L.P. | 101,500 | $3,657,045 | 2.60% |